237 related articles for article (PubMed ID: 35216566)
1. In vitro inactivation of SARS-CoV-2 using a povidone-iodine oral rinse.
Shet M; Westover J; Hong R; Igo D; Cataldo M; Bhaskar S
BMC Oral Health; 2022 Feb; 22(1):47. PubMed ID: 35216566
[TBL] [Abstract][Full Text] [Related]
2. In Vitro Evaluation of the Virucidal Activity of Different Povidone-Iodine Formulations Against Murine and Human Coronaviruses.
Shet M; Hong R; Igo D; Cataldo M; Bhaskar S
Infect Dis Ther; 2021 Dec; 10(4):2777-2790. PubMed ID: 34581973
[TBL] [Abstract][Full Text] [Related]
3. Rapid In-Vitro Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Using Povidone-Iodine Oral Antiseptic Rinse.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Jul; 29(6):529-533. PubMed ID: 32511851
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
5. Comparison of In Vitro Inactivation of SARS CoV-2 with Hydrogen Peroxide and Povidone-Iodine Oral Antiseptic Rinses.
Bidra AS; Pelletier JS; Westover JB; Frank S; Brown SM; Tessema B
J Prosthodont; 2020 Aug; 29(7):599-603. PubMed ID: 32608097
[TBL] [Abstract][Full Text] [Related]
6. Virucidal effect of povidone-iodine against SARS-CoV-2
Wang Y; Wu Y; Wang Q; Zhu J; Shi W; Han Z; Zhang Y; Chen K
J Int Med Res; 2021 Dec; 49(12):3000605211063695. PubMed ID: 34914884
[TBL] [Abstract][Full Text] [Related]
7. In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2.
Frank S; Brown SM; Capriotti JA; Westover JB; Pelletier JS; Tessema B
JAMA Otolaryngol Head Neck Surg; 2020 Nov; 146(11):1054-1058. PubMed ID: 32940656
[TBL] [Abstract][Full Text] [Related]
8. Virucidal Properties of Molecular Iodine Oral Rinse Against SARS-CoV-2.
Teagle V; Clem DS; Yoon T
Compend Contin Educ Dent; 2022 Feb; 43(2):e13-e16. PubMed ID: 35148480
[TBL] [Abstract][Full Text] [Related]
9. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease.
Anderson DE; Sivalingam V; Kang AEZ; Ananthanarayanan A; Arumugam H; Jenkins TM; Hadjiat Y; Eggers M
Infect Dis Ther; 2020 Sep; 9(3):669-675. PubMed ID: 32643111
[TBL] [Abstract][Full Text] [Related]
10. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of "Essential Iodine Drops" against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Köntös Z
PLoS One; 2021; 16(7):e0254341. PubMed ID: 34242340
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of the virucidal efficacy of chlorhexidine and povidone-iodine mouthwashes against salivary SARS-CoV-2. A randomized-controlled clinical trial.
Elzein R; Abdel-Sater F; Fakhreddine S; Hanna PA; Feghali R; Hamad H; Ayoub F
J Evid Based Dent Pract; 2021 Sep; 21(3):101584. PubMed ID: 34479668
[TBL] [Abstract][Full Text] [Related]
13. Effective
Davies K; Buczkowski H; Welch SR; Green N; Mawer D; Woodford N; Roberts ADG; Nixon PJ; Seymour DW; Killip MJ
J Gen Virol; 2021 Apr; 102(4):. PubMed ID: 33913803
[TBL] [Abstract][Full Text] [Related]
14. Repurposing 0.5% povidone iodine solution in otorhinolaryngology practice in Covid 19 pandemic.
Khan MM; Parab SR; Paranjape M
Am J Otolaryngol; 2020; 41(5):102618. PubMed ID: 32574894
[TBL] [Abstract][Full Text] [Related]
15. The short-term effect of different chlorhexidine forms versus povidone iodine mouth rinse in minimizing the oral SARS-CoV-2 viral load: An open label randomized controlled clinical trial study.
Natto ZS; Bakhrebah MA; Afeef M; Al-Harbi S; Nassar MS; Alhetheel AF; Ashi H
Medicine (Baltimore); 2022 Jul; 101(30):e28925. PubMed ID: 35905275
[TBL] [Abstract][Full Text] [Related]
16. Repurposing povidone-iodine to reduce the risk of SARS-CoV-2 infection and transmission: a narrative review.
Lim NA; Teng O; Ng CYH; Bao LXY; Tambyah PA; Quek AML; Seet RCS
Ann Med; 2022 Dec; 54(1):1488-1499. PubMed ID: 35594333
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Mouth Rinses and Nasal Spray in the Inactivation of SARS-CoV-2: A Systematic Review and Meta-Analysis of
Idrees M; McGowan B; Fawzy A; Abuderman AA; Balasubramaniam R; Kujan O
Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231450
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Bactericidal and Virucidal Efficacy of Povidone-Iodine Gargle/Mouthwash Against Respiratory and Oral Tract Pathogens.
Eggers M; Koburger-Janssen T; Eickmann M; Zorn J
Infect Dis Ther; 2018 Jun; 7(2):249-259. PubMed ID: 29633177
[TBL] [Abstract][Full Text] [Related]
19. In vitro virucidal activity of povidone iodine gargle and mouthwash against SARS-CoV-2: implications for dental practice.
Hassandarvish P; Tiong V; Mohamed NA; Arumugam H; Ananthanarayanan A; Qasuri M; Hadjiat Y; Abubakar S
Br Dent J; 2020 Dec; ():1-4. PubMed ID: 33303923
[TBL] [Abstract][Full Text] [Related]
20. The effectiveness of mouthwash against SARS-CoV-2 infection: A review of scientific and clinical evidence.
Chen MH; Chang PC
J Formos Med Assoc; 2022 May; 121(5):879-885. PubMed ID: 34666923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
